569 related articles for article (PubMed ID: 11805076)
21. Reconstitution of C.B-17 scid mice with BALB/c T cells initiates a T helper type-1 response and renders them capable of healing Leishmania major infection.
Varkila K; Chatelain R; Leal LM; Coffman RL
Eur J Immunol; 1993 Jan; 23(1):262-8. PubMed ID: 8419179
[TBL] [Abstract][Full Text] [Related]
22. Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis.
Webb JR; Kaufmann D; Campos-Neto A; Reed SG
J Immunol; 1996 Dec; 157(11):5034-41. PubMed ID: 8943412
[TBL] [Abstract][Full Text] [Related]
23. Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development.
Güler ML; Gorham JD; Hsieh CS; Mackey AJ; Steen RG; Dietrich WF; Murphy KM
Science; 1996 Feb; 271(5251):984-7. PubMed ID: 8584935
[TBL] [Abstract][Full Text] [Related]
24. Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4.
Mocci S; Coffman RL
J Immunol; 1995 Apr; 154(8):3779-87. PubMed ID: 7706719
[TBL] [Abstract][Full Text] [Related]
25. Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.
Radwanska M; Cutler AJ; Hoving JC; Magez S; Holscher C; Bohms A; Arendse B; Kirsch R; Hunig T; Alexander J; Kaye P; Brombacher F
PLoS Pathog; 2007 May; 3(5):e68. PubMed ID: 17500591
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-4-independent acceleration of cutaneous leishmaniasis in susceptible BALB/c mice following treatment with anti-CTLA4 antibody.
Heinzel FP; Maier RA
Infect Immun; 1999 Dec; 67(12):6454-60. PubMed ID: 10569763
[TBL] [Abstract][Full Text] [Related]
27. Maintenance of IL-12-responsive CD4+ T cells during a Th2 response in Leishmania major-infected mice.
Hondowicz BD; Park AY; Elloso MM; Scott P
Eur J Immunol; 2000 Jul; 30(7):2007-14. PubMed ID: 10940890
[TBL] [Abstract][Full Text] [Related]
28. Susceptibility to Leishmania major infection in interleukin-4-deficient mice.
Noben-Trauth N; Kropf P; Müller I
Science; 1996 Feb; 271(5251):987-90. PubMed ID: 8584936
[TBL] [Abstract][Full Text] [Related]
29. Susceptibility or resistance to Leishmania infection is dictated by the macrophages evolved under the influence of IL-3 or GM-CSF.
Saha B; Saini A; Germond R; Perrin PJ; Harlan DM; Davis TA
Eur J Immunol; 1999 Jul; 29(7):2319-29. PubMed ID: 10427995
[TBL] [Abstract][Full Text] [Related]
30. Early IL-4 production does not predict susceptibility to Leishmania major.
Scott P; Eaton A; Gause WC; di Zhou X; Hondowicz B
Exp Parasitol; 1996 Nov; 84(2):178-87. PubMed ID: 8932767
[TBL] [Abstract][Full Text] [Related]
31. Paradoxical effects of IL-12 in leishmaniasis in the presence and absence of vaccinating antigen.
Noormohammadi AH; Hochrein H; Curtis JM; Baldwin TM; Handman E
Vaccine; 2001 Jul; 19(28-29):4043-52. PubMed ID: 11427281
[TBL] [Abstract][Full Text] [Related]
32. IL-12Rbeta2-deficient mice of a genetically resistant background are susceptible to Leishmania major infection and develop a parasite-specific Th2 immune response.
Chakir H; Campos-Neto A; Mojibian M; Webb JR
Microbes Infect; 2003 Apr; 5(4):241-9. PubMed ID: 12706437
[TBL] [Abstract][Full Text] [Related]
33. In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease.
Himmelrich H; Launois P; Maillard I; Biedermann T; Tacchini-Cottier F; Locksley RM; Röcken M; Louis JA
J Immunol; 2000 May; 164(9):4819-25. PubMed ID: 10779790
[TBL] [Abstract][Full Text] [Related]
34. In vivo blocking of L-selectin rescues BALB/c mice from fatal Leishmania major infection.
Laskay T; Wittmann I; Diefenbach A; Röllinghoff M; Solbach W
Immunol Lett; 1997 Jun; 57(1-3):89-91. PubMed ID: 9232431
[TBL] [Abstract][Full Text] [Related]
35. IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice.
Biedermann T; Zimmermann S; Himmelrich H; Gumy A; Egeter O; Sakrauski AK; Seegmüller I; Voigt H; Launois P; Levine AD; Wagner H; Heeg K; Louis JA; Röcken M
Nat Immunol; 2001 Nov; 2(11):1054-60. PubMed ID: 11600887
[TBL] [Abstract][Full Text] [Related]
36. Early production of IL-4 and induction of Th2 responses in the lymph node originate from an MHC class I-independent CD4+NK1.1- T cell population.
von der Weid T; Beebe AM; Roopenian DC; Coffman RL
J Immunol; 1996 Nov; 157(10):4421-7. PubMed ID: 8906817
[TBL] [Abstract][Full Text] [Related]
37. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity.
Kamanaka M; Yu P; Yasui T; Yoshida K; Kawabe T; Horii T; Kishimoto T; Kikutani H
Immunity; 1996 Mar; 4(3):275-81. PubMed ID: 8624817
[TBL] [Abstract][Full Text] [Related]
38. Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB/c mice against Leishmania major infection.
Hugentobler F; Di Roberto RB; Gillard J; Cousineau B
Vaccine; 2012 Aug; 30(39):5726-32. PubMed ID: 22814408
[TBL] [Abstract][Full Text] [Related]
39. The immunodominant T helper 2 (Th2) response elicited in BALB/c mice by the Leishmania LiP2a and LiP2b acidic ribosomal proteins cannot be reverted by strong Th1 inducers.
Iborra S; Abánades DR; Parody N; Carrión J; Risueño RM; Pineda MA; Bonay P; Alonso C; Soto M
Clin Exp Immunol; 2007 Nov; 150(2):375-85. PubMed ID: 17900304
[TBL] [Abstract][Full Text] [Related]
40. Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis.
Iborra S; Soto M; Carrión J; Alonso C; Requena JM
Vaccine; 2004 Sep; 22(29-30):3865-76. PubMed ID: 15364433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
